Cargando…
Converting monoclonal antibody-based immunotherapies from passive to active: bringing immune complexes into play
Monoclonal antibodies (mAbs), which currently constitute the main class of biotherapeutics, are now recognized as major medical tools that are increasingly being considered to fight severe viral infections. Indeed, the number of antiviral mAbs developed in recent years has grown exponentially. Altho...
Autores principales: | Lambour, Jennifer, Naranjo-Gomez, Mar, Piechaczyk, Marc, Pelegrin, Mireia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5034104/ https://www.ncbi.nlm.nih.gov/pubmed/27530750 http://dx.doi.org/10.1038/emi.2016.97 |
Ejemplares similares
-
Antiviral Monoclonal Antibodies: Can They Be More Than Simple Neutralizing Agents?
por: Pelegrin, Mireia, et al.
Publicado: (2015) -
Differential and sequential immunomodulatory role of neutrophils and Ly6C(hi) inflammatory monocytes during antiviral antibody therapy
por: Lambour, Jennifer, et al.
Publicado: (2021) -
Immunomodulatory Role of NK Cells during Antiviral Antibody Therapy
por: Naranjo-Gomez, Mar, et al.
Publicado: (2021) -
A Crucial Role for Infected-Cell/Antibody Immune Complexes in the Enhancement of Endogenous Antiviral Immunity by Short Passive Immunotherapy
por: Michaud, Henri-Alexandre, et al.
Publicado: (2010) -
Regulatable systemic production of monoclonal antibodies by in vivo muscle electroporation
por: Perez, Norma, et al.
Publicado: (2004)